Document Detail


Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
MedLine Citation:
PMID:  16152703     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
NRTIs are cornerstones of antiretroviral therapy and perhaps the most important drugs developed for AIDS treatment. Judicious use of NRTIs in the fight against HIV infection has afforded significant clinical advances in AIDS treatment. Nonetheless, it is axiomatic to expect side effects from NRTIs as well. A principal toxicity of NRTIs relates to chronic and cumulative MT in various tissues. The long-term impact of this toxicity on affected patients is not clear except in extreme cases where morbidity was severe and mortality occurred. Because of chronicity and potential for severity, NRTI MT remains an important clinical problem. Further studies will help us unravel mechanisms of NRTI MT and the natural history of mitochondrial biogenesis in humans and other mammalian systems.
Authors:
William Lewis
Related Documents :
10519853 - Music therapy helping to work through grief and finding a personal identity.
11872183 - Aids and aids-treatment neuropathies.
11557843 - Biogeography and ecological setting of indian ocean hydrothermal vents.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Antiviral therapy     Volume:  10 Suppl 2     ISSN:  1359-6535     ISO Abbreviation:  Antivir. Ther. (Lond.)     Publication Date:  2005  
Date Detail:
Created Date:  2005-09-12     Completed Date:  2005-09-29     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9815705     Medline TA:  Antivir Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  M13-27     Citation Subset:  IM    
Affiliation:
Department of Pathology, Emory University, Atlanta, GA, USA. wlewis@emory.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acquired Immunodeficiency Syndrome / drug therapy*
Anti-HIV Agents / adverse effects*
DNA Replication / drug effects
DNA, Mitochondrial / analysis*
Didanosine / adverse effects
Humans
Lamivudine / adverse effects
Mitochondria / drug effects*
Nucleosides / adverse effects*
Reverse Transcriptase Inhibitors / adverse effects*
Stavudine / adverse effects
Zidovudine / adverse effects
Grant Support
ID/Acronym/Agency:
HL063666/HL/NHLBI NIH HHS; HL072707/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Anti-HIV Agents; 0/DNA, Mitochondrial; 0/Nucleosides; 0/Reverse Transcriptase Inhibitors; 134678-17-4/Lamivudine; 30516-87-1/Zidovudine; 3056-17-5/Stavudine; 69655-05-6/Didanosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during H...
Next Document:  HIV protease inhibitors prevent mitochondrial hyperpolarization and redox imbalance and decrease end...